Neurogene Inc. (NGNE) ownership: Samsara BioCapital, L.P. 19% · institutions 92% (13F 2026-03-31). Insider activity, 90 days: Routine (5 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Samsara Biocapital, LLC | 1717127.00 | $34.62M | 8.6% | 2026-03-31 |
| Janus Henderson | 709469.00 | $29.78M | 3.5% | 2026-03-31 |
| Redmile Group, LLC | 1459599.00 | $29.43M | 7.3% | 2026-03-31 |
| Casdin Capital, LLC | 1420361.00 | $28.63M | 7.1% | 2026-03-31 |
| RTW Investments, LP | 1362456.00 | $27.47M | 6.8% | 2026-03-31 |
| EcoR1 Capital, LLC | 1271342.00 | $25.63M | 6.4% | 2026-03-31 |
| BlackRock | 1005070.00 | $20.26M | 5.0% | 2026-03-31 |
| Baker BROS. Advisors LP | 991691.00 | $19.99M | 5.0% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-06 | |
| Sell | null | 2026-07-06 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 |
Back to NGNE overview · NGNE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.